Mycobacterium avium complex immune reconstitution inflammatory syndrome: Long term outcomes
2007

Long-term outcomes of Mycobacterium avium complex in HIV patients

Sample size: 20 publication Evidence: low

Author Information

Author(s): James IV Riddell, Daniel R Kaul, Petros C Karakousis, Joel E Gallant, Jennifer Mitty, Powel H Kazanjian

Primary Institution: University of Michigan Health System

Hypothesis

What are the long-term outcomes of patients with Mycobacterium avium complex immune reconstitution inflammatory syndrome (IRIS) after treatment?

Conclusion

The majority of patients with MAC IRIS eventually responded to treatment.

Supporting Evidence

  • 80% of patients responded to treatment and were disease-free after a mean of 17.4 months.
  • The mean CD4 cell count increased from 24/mm3 at baseline to 100/mm3 at MAC IRIS diagnosis.
  • Responders tended to have peripheral rather than intra-abdominal adenopathy.

Takeaway

Most people with a specific infection related to their HIV treatment got better after taking medicine for a while.

Methodology

Retrospective identification of MAC IRIS cases at four HIV clinics from 1996 to 2004.

Limitations

The sample size was not adequate for statistical analysis.

Participant Demographics

17 males, 12 Caucasian, 7 African-American, 1 Hispanic; mean age 40 years.

Digital Object Identifier (DOI)

10.1186/1479-5876-5-50

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication